Navigation Links
Express Scripts Names Cathy R. Smith Chief Financial Officer
Date:1/14/2014

ST. LOUIS, Jan. 14, 2014 /PRNewswire/ -- Express Scripts Holding Company (NASDAQ: ESRX) today announced that Cathy R. Smith will join the company as Executive Vice President and Chief Financial Officer, effective February 10, 2014.

(Logo:  http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO)

She will join Express Scripts from Walmart, where she has been executive vice president of strategy and chief financial officer for Walmart International since February 2010. Before joining Walmart, she was executive vice president and chief financial officer at GameStop. Prior to GameStop, she held executive vice president and chief financial officer roles at Centex Corp., a leading U.S. homebuilder, and Kennametal, a global industrial tool manufacturer. Earlier in her career, she served in various finance roles for 18 years in aerospace/defense companies.

"Cathy has demonstrated a solid track record of success at leading companies in diverse industries, and we believe her background is a great fit for Express Scripts," said George Paz, chairman and chief executive officer. "We look forward to welcoming Cathy and expect she will make important contributions to our continued growth."

About Express Scripts

Express Scripts manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science, our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. 

For more information, visit Lab.Express-Scripts.com  or follow @ExpressScripts on Twitter.

Media Contact:
Brian Henry
314-684-6438
bhenry@express-scripts.com

Investor Contact:
David Myers
314-810-3115
investor.relations@express-scripts.com


'/>"/>
SOURCE Express Scripts Holding Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Oncology On Canvas: Expressions of a Cancer Journey Reaches Important Milestone With 2014 Competition
2. Express Scripts Announces Accelerated Share Repurchase Transaction
3. Lipitor Lawsuit News: As Lipitor Diabetes Lawsuits Move Forward, Bernstein Liebhard LLP Comments on JAMA Editorial Expressing Concern about the "Statinization" of U.S.
4. Financial Results, New Drug Applications, and Stock Price Movements - Research Report on Endo, Bristol-Myers Squibb, Express Scripts, AbbVie, and Incyte
5. Express Scripts to Present at the Credit Suisse Healthcare Conference
6. Express Scripts Launches Workers Compensation Program To Help Payers Reduce Narcotic Abuse
7. Express Scripts Reports Third Quarter 2013 Results
8. Ventana receives approval from Chinas FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients
9. Express Scripts Acquires SmartD Medicare Prescription Drug Plan; Adds to Industry-Leading Medicare Offering
10. Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
11. Express Scripts To Discuss Outlook for Future Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Somnoware, a leading provider of ... with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device ... this platform, initializing devices and importing studies are just one-click operations. This plugin ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... is sharing bold recipes for Memorial Day entertaining that are sure to satisfy ... “Boar’s Head fresh sliced meats and cheeses featured in these refreshingly balanced recipes ...
(Date:5/26/2017)... BOSTON, MA (PRWEB) , ... May 26, 2017 , ... ... Care Act (AHCA), which narrowly passed the U.S. House on May 4, would result ... would be expected under continued implementation of the 2010 Patient Protection and Affordable Care ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... week that is focusing on the Peace Agreements being discussed by President Donald Trump ... in a race to try to speed up peace talks in the continuous battle ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using ... Viewers can reconnect with America as it explores some of the best places to ... for an inventive new place for a family vacation, and have discovered hiking. Many ...
Breaking Medicine News(10 mins):